Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial

Investigating the roles of hyperglycaemia, hyperinsulinaemia and elevated free fatty acids in cardiac function in patients with type 2 diabetes via treatment with insulin compared with empagliflozin: protocol for the HyperCarD2 randomised, crossover trial

Introduction Type 2 diabetes (T2D) is characterised by elevated plasma glucose, free fatty acid (FFA) and insulin concentrations, and this metabolic profile is linked to diabetic cardiomyopathy, a diastolic dysfunction at first and increased cardiovascular disease (CVD) risk. Shifting cardiac metabo...

Full description

Bibliographic Details
Main Authors: Jens Juul Holst, Sten Madsbad, Niels Vejlstrup, Ulrik Dixen, Mogens Fenger, Per Lav Madsen, Jens Peter Goetze, Roopameera Thirumathyam, Erik Arne Richter, Gerrit Van Hall, Nils Bruun Jørgensen
Format: Article
Language:English
Published: BMJ Publishing Group 2022-08-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/12/8/e054100.full

Internet

https://bmjopen.bmj.com/content/12/8/e054100.full

Similar Items